# US 2022/0054383 A1 · Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0054383 A1
- Document ID: US20220054383A1
- Status: Published application
- Kind: A1
- Application number: 17/392,603
- Filed: 2021-08-03
- Published: 2022-02-24
- Earliest claimed: 2011-10-31
- Assignees: Kane Biotech Inc.
- Applicants: Kane Biotech Inc.
- Inventors: Purushottam V. GAWANDE; Karen LOVETRI; Nandadeva YAKANDAWALA; Gord FROEHLICH; Srinivasa MADHYASTHA
- Web page: https://patentgrep.com/patent/US20220054383A1

## CPC

- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A01N 37/04: polybasic
- A01N 37/44: containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N 59/16: Heavy metals; Compounds thereof
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61B 3/125: with contact lenses
- A61C 11/005: {with tracing devices}
- A61K 8/27: Zinc; Compounds thereof
- A61K 8/362: Polycarboxylic acids
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 33/30: Zinc; Compounds thereof
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61Q 3/00: Manicure or pedicure preparations
- A61Q 17/005: {Antimicrobial preparations}
- A61K 2800/70: Biological properties of the composition as a whole
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Compositions comprising one or more chelating agents and optionally zinc ion salts are used to inhibit the growth or biofilm formation in bacteria associated with personal care products such as ophthalmic, pedicure, manicure or podiatric solutions. The compositions of the present application can also comprise gelling agents, antimicrobials, antibiotic or a pH adjuster. The compositions may be in the form of a solution, a gel, a cream, a jelly, a powder, a paste, a lotion, soap and a cleaner.

## Claims

### Claim at position 1

1-36. (canceled)

### Claim 37

A composition for inhibiting growth of bacteria and biofilm, the composition comprising:
(a) water;
(b) one or more chelating agents selected from the group consisting of disodium or tetrasodium EDTA at a concentration of at least about 125 mg/L;
(c) one or more chelating agents selected from the group consisting of sodium citrate and potassium citrate, at a concentration of at least about 3,000 mg/L; and
(d) a zinc salt selected from the group consisting of zinc chloride, zinc gluconate, zinc lactate, zinc citrate, zinc sulfate, and zinc acetate at a concentration of at least about 100 mg/L.

### Claim 38 (depends on 37)

The composition of claim 37, wherein the zinc salt is zinc chloride or zinc citrate.

### Claim 39 (depends on 37)

The composition of claim 37, further comprising an antimicrobial preservative selected from one or more of potassium sorbate, potassium benzoate, sodium benzoate and benzoic acid.

### Claim 40 (depends on 37)

The composition of claim 37, further comprising one or more ingredients selected from the group consisting of: water, a buffer, a stabilizing agent, a gelling agent, a surfactant, a herbal, a vitamin, a mineral, an extra cellular matrix, an antimicrobial, an antibiotic, and a pH adjuster.

### Claim 41 (depends on 37)

The composition of claim 37 prepared as one or more of a disinfecting solution, a dip solution, a lotion, a cream, an ointment, a gel, and a spray.

### Claim 42 (depends on 37)

The composition as claimed in claim 37, wherein the composition comprises a liposome or nanoparticle or a suitable device delivery system.

### Claim 43 (depends on 37)

The composition as claimed in claim 37, further comprising an anti-infective compound selected from the group consisting of glycoside hydrolase of Aggregatibacter actinomycetemcomitans. alginate lyase, nisin, lactoferricin, serotransferrin, ovotransferrin, ovalbumin, ovomucoid, protamine sulfate, chlorhexidine, cetylpyridinium chloride, triclosan, silver sulfadiazine, benzalkonium chloride, hydrogen peroxide, citric acid, potassium citrate, 5-fluorouracil, cis-2-decenoic acid, DNase I, proteinase K, silver, gallium, silver, bacteriocins and antimicrobial peptides.

### Claim 44 (depends on 37)

The composition as claimed in claim 37 further comprising one or more of viscosity enhancing agents, lubricants, surfactants, buffers, preservatives, and salts.

### Claim 45 (depends on 37)

The composition as claimed in claim 37, wherein the composition is selected from a solution, a gel, a cream, a jelly, a powder, a paste, a lotion, a soap and a cleaner.

### Claim 46 (depends on 37)

A method of preventing or treating ophthalmic biofilm growth, the method comprising administering the composition of claim 37 to a user.

### Claim 47 (depends on 37, 46)

The method of claim 46, wherein the method further comprises administering the composition of claim 37 to the eye of a user.

### Claim 48 (depends on 46)

The method of claim 46, wherein the method further comprises administering the composition of 37 to a foot, fingernail, or toenail of a user.

### Claim 49 (depends on 37)

A personal care device treated or impregnated with the composition of claim 37.

### Claim 50 (depends on 49)

The personal care device of claim 49, wherein the composition is selected from a solution, a gel, a cream, a jelly, a powder, a paste, a lotion, a soap and a cleaner.

### Claim 51 (depends on 49)

The personal care device of claim 49, further comprising one or more of a contact lens and a contact lens container.

### Claim 52 (depends on 49)

The personal care device of claim 49, further comprising one or more of a hand washing container, a scrubber, and a foot washing container.
